Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study.
CORONA HOTSPOT
COVID-19
CROSS-SECTIONAL STUDY
SARS-COV-2
SEROLOGICAL STUDY
STUDY PROTOCOL
Journal
Journal of health monitoring
ISSN: 2511-2708
Titre abrégé: J Health Monit
Pays: Germany
ID NLM: 101757730
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
28
07
2020
accepted:
06
08
2020
entrez:
11
2
2022
pubmed:
18
11
2020
medline:
18
11
2020
Statut:
epublish
Résumé
At a regional and local level, the COVID-19 pandemic has not spread out uniformly and some German municipalities have been particularly affected. The seroepidemiological data from these areas helps estimate the proportion of the population that has been infected with SARS-CoV-2 (seroprevalence), as well as the number of undetected infections and asymptomatic cases. In four municipalities which were especially affected, 2,000 participants will be tested for an active SARS-CoV-2 infection (oropharyngeal swab) or a past infection (blood specimen IgG antibody test). Participants will also be asked to fill out a short written questionnaire at study centres and complete a follow-up questionnaire either online or by telephone, including information on issues such as possible exposure, susceptability, symptoms and medical history. The CORONA-MONITORING lokal study will allow to determine the proportion of the population with SARS-CoV-2 antibodies in four particularly affected locations. This study will increase the accuracy of estimates regarding the scope of the epidemic, help determine risk and protective factors for an infection and therefore also identify especially exposed groups and, as such, it will be crucial towards planning of prevention measures.
Identifiants
pubmed: 35146295
doi: 10.25646/7053
pmc: PMC8734078
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2-16Informations de copyright
© Robert Koch Institute. All rights reserved unless explicitly granted.
Déclaration de conflit d'intérêts
Conflicts of interest The authors declared no conflicts of interest.
Références
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):620-30
pubmed: 23703478
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Jul;58(7):749-57
pubmed: 25986532
Lancet Infect Dis. 2020 Aug;20(8):920-928
pubmed: 32422201
Indian J Public Health. 2020 Jun;64(Supplement):S139-S141
pubmed: 32496245
Br J Psychiatry. 1995 Jan;166(1):29-34
pubmed: 7894872
J Hosp Infect. 2020 Jun;105(2):111-112
pubmed: 32277963
Arch Public Health. 2017 Sep 18;75:40
pubmed: 28936356